Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Novel agent for treatment-refractory CIS now under review in Canada

Feb. 3, 2000

Telik initiates clinical testing of first development candidate

Feb. 3, 2000

Apoptotic and antibacterial cyclohexapeptide fungal metabolite discovered in Japan

Feb. 2, 2000

Improved anticancer anthracene derivatives designed at BTG

Feb. 2, 2000

Isis compounds modulate expression of antiapoptotic proteins A1 and mcl-1

Feb. 2, 2000

EntreMed to commence phase I trial of Angiostatin protein

Feb. 1, 2000

Kosan develops efficient production system for potent anticancer drugs

Feb. 1, 2000

Techniclone licenses novel antiangiogenic antibody

Feb. 1, 2000

Cell Pathways signs commercialization agreement for Aptosyn

Feb. 1, 2000

ADIR's new MMP and TNF-alpha production inhibitors described in recent patent

Jan. 31, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026